Results 151 to 160 of about 729,299 (226)

Low-Dose Fisetin Supplementation and Its Association With Chronic Inflammation in Middle-Aged and Older Adults: Study Protocol for a Triple-Blind, Randomised, Placebo-Controlled Trial. [PDF]

Basic Clin Pharmacol Toxicol
Tavenier J, Berglind M, Hach LF, Christensen LWS, Masarikova MJ, Yahya R, Lindstrøm MB, Jawad BN, Zatkova A, Nielsen RL, Juul-Larsen HG, Kallemose T, Nehlin JO, Houlind MB, Andersen O, Rasmussen LJH.   +15 more
europepmc   +1 more source

Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. [PDF]

Clin Exp Metastasis
Spartz A, Schmidt S, Mohamed F, Troness B, Lange CA, El-Ashry D.   +5 more
europepmc   +1 more source

Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness. [PDF]

Am J Respir Cell Mol Biol
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, Papas BN, Gruzdev A, Ray M, Nakano H, Cook DN.   +10 more
europepmc   +1 more source

The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]

Rev Assoc Med Bras (1992)
Gülüm C, Eroğlu P, Tanrıverdi R, Bozlu M.   +3 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source

Tissue-Based Multiomic Exploratory Analysis of the Urokinase Plasminogen Activator/uPAR System and Matrix Metalloproteinases in Stroma AReactive Invasion Front Areas-Positive Gastrointestinal Cancers.

Pathobiology
Reitsam NG, Grosser B, Dintner S, Grozdanov V, Sommer F, Heyer C, Schlesner M, Hardt J, Franz S, Schenkirsch G, Probst A, Löhr P, Waidhauser J, Märkl B.   +13 more
europepmc   +1 more source

Integrin α5β1 mediates the inhibitory effects of vasoinhibin on angiogenesis and vascular permeability. [PDF]

J Biol Chem
Zamora M, Clapp C, Martínez de la Escalera G, Robles JP.   +3 more
europepmc   +1 more source

Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer. [PDF]

Explor Target Antitumor Ther
Izuegbuna OO.
europepmc   +1 more source

Predictive Value of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) and Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) for Biochemical Recurrence After Radical Prostatectomy. [PDF]

Med Sci Monit
Wang H, Huang C.
europepmc   +1 more source

Targeted Interference with USF2 Binding to the SERPINE1 Proximal Promoter E-Box in Dual Mutant p53^R282Q,H179Y Human Keratinocytes Inhibits Serum-/TGF-β1-Induced SERPINE1 Expression and Stimulates Epithelial Cell Proliferation. [PDF]

Biomedicines
Higgins SP, Czekay RP, Higgins CE, Higgins PJ.   +3 more
europepmc   +1 more source